alexa
Reach Us +44-1904-929220
Editor - Priyanka Trivedi | Mayo Clinic | 14715
ISSN-2155-9929

Journal of Molecular Biomarkers & Diagnosis
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

15th Global Biomarkers and Clinical Research Summit

Vienna, Austria

2nd International Conference on Biomarkers and Cancer Targets

Capetown, South Africa
Share This Page

Priyanka Trivedi

Priyanka Trivedi
Priyanka Trivedi
Biochemistry and Molecular Biology
Mayo Clinic
Johnson Medical Research Building
Scottsdale, USA
Mayo Clinic

Biography

Priyanka P. Trivedi, a Postdoctoral Research Fellow at Mayo Clinic, Scottsdale, Arizona, USA. She did her Ph.D. from the National Institute of Pharmaceutical Education and Research, India. she has published papers in various peer-reviewed journals and has also served as a reviewer for some international journals.

Research Interest

Area of research interest includes vaccine-based cancer immunotherapy, ulcerative colitis, colon cancer, pre-clinical toxicology, genotoxicity, hepatotoxicity, cardiotoxicity, nephrotoxicity, germ cell toxicity and reproductive toxicity.

Certificate

Certificate

Global Speakers in the subject

Global Experts in the subject

Journal of Molecular Biomarkers & Diagnosis - MUC1 in cell adhesion


Priyanka Trivedi
Biochemistry and Molecular Biology
Mayo Clinic
Johnson Medical Research Building
Scottsdale, USA

 
Download PPT PPT Views: 249 Updated on: 2015-10-14 For Recent Update: Click here
 
 
Download PDF   PDF Views: 249  Updated on: 2015-10-14 For Recent Update: Click here
 
Relevant Topics
Top